Artificial Intelligence in Pharmacovigilance
Abstract
Abstract: Pharmacovigilance (PV) is a data-driven method that quickly identifies medication safety risks by processing reports of suspected Adverse Events (AEs) and extracting health data. The first steps in the PV case processing cycle include data collection, data entry, coding, preliminary validity and completeness checks, and medical evaluation for severity, seriousness, expectation, and causality. Afterward, a report is submitted, quality is checked, and data storage and maintenance are performed. This process is costly and time-consuming, as it requires both a workforce and technology. Conversely, artificial intelligence (AI) is used to reduce this time investment and increase data accuracy. AI includes machine learning methods like deep learning and natural language processing, which can recognize and retrieve information on adverse drug occurrences. By doing so, it is possible to optimize the pharmacovigilance process and improve the tracking of documented adverse medication occurrences. AI's advancement in pharmacovigilance raises concerns about potential changes in drug safety professionals' roles, prompting curiosity about their future in an AI-assisted workplace. Artificial Intelligence (AI) should augment human intelligence, not replace human specialists. It's crucial to highlight and ensure AI improves PV more than it causes problems. The pharmaceutical business faces significant obstacles and opportunities, especially when it comes to implementing and…
Read the paper
Related studies
- Impact of antibiotics on the human microbiome and consequences for host health
- Antibiotics in the clinical pipeline in October 2019
- The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan
- Research Communications of the 32nd ECVIM-CA Online Congress
- Singlet-Oxygen Therapy. Scientific And Methodological Materials
- Software modeling for better understanding of pharmacokinetic-pharmacodynamic relationships: application to azithromycin in the treatment of streptococcal tonsillitis and in acute exacerbation fo chronic bronchitis]
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.